Literature DB >> 19008215

Problem-solving therapy for psychological distress in Japanese cancer patients: preliminary clinical experience from psychiatric consultations.

Tatsuo Akechi1, Kei Hirai, Hiroko Motooka, Mariko Shiozaki, Junwen Chen, Kanae Momino, Toru Okuyama, Toshiaki A Furukawa.   

Abstract

Problem-solving therapy (PST) is a brief, structured psychological treatment. Preliminary clinical findings regarding the effectiveness of PST for treating psychological distress experienced by Japanese cancer patients are presented. Our actual clinical experience in administering PST to four consecutive distressed cancer patients was reviewed. All of the patients were breast cancer survivors who were referred to us after undergoing surgery. Three cases received six PST sessions each and one case received three PST sessions. The depression and anxiety scores decreased after PST. Our preliminary experience suggests that PST is an effective treatment for alleviating psychological distress in Japanese cancer patients and that this treatment should be further examined in a clinical trial.

Entities:  

Mesh:

Year:  2008        PMID: 19008215     DOI: 10.1093/jjco/hyn115

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  2 in total

1.  Collaborative care intervention for the perceived care needs of women with breast cancer undergoing adjuvant therapy after surgery: a feasibility study.

Authors:  Kanae Momino; Miyashita Mitsunori; Hiroko Yamashita; Tatsuya Toyama; Hiroshi Sugiura; Nobuyasu Yoshimoto; Kei Hirai; Tatsuo Akechi
Journal:  Jpn J Clin Oncol       Date:  2017-03-01       Impact factor: 3.019

2.  Smartphone problem-solving and behavioural activation therapy to reduce fear of recurrence among patients with breast cancer (SMartphone Intervention to LEssen fear of cancer recurrence: SMILE project): protocol for a randomised controlled trial.

Authors:  Tatsuo Akechi; Takuhiro Yamaguchi; Megumi Uchida; Fuminobu Imai; Kanae Momino; Fujika Katsuki; Naomi Sakurai; Tempei Miyaji; Masaru Horikoshi; Toshi A Furukawa; Hiroji Iwata; Yosuke Uchitomi
Journal:  BMJ Open       Date:  2018-11-08       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.